ORDINARY SHARE PURCHASE WARRANT Nabriva Therapeutics plcOrdinary Share Purchase Warrant • March 1st, 2021 • Nabriva Therapeutics PLC • Pharmaceutical preparations • New York
Contract Type FiledMarch 1st, 2021 Company Industry JurisdictionTHIS ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value of $0.0001 received by the Company, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after March __, 2021 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on March __, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Nabriva Therapeutics plc, an Irish incorporated public limited company (the “Company”), up to ______ Ordinary Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 1st, 2021 • Nabriva Therapeutics PLC • Pharmaceutical preparations • New York
Contract Type FiledMarch 1st, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 1, 2021, between Nabriva Therapeutics plc, an Irish incorporated public limited company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
ORDINARY SHARE PRE-FUNDED PURCHASE WARRANT Nabriva Therapeutics plcOrdinary Share Pre-Funded Purchase Warrant • March 1st, 2021 • Nabriva Therapeutics PLC • Pharmaceutical preparations • New York
Contract Type FiledMarch 1st, 2021 Company Industry JurisdictionTHIS ORDINARY SHARE PRE-FUNDED PURCHASE WARRANT (the “Warrant”) certifies that, for value received by the Company, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after March __2021 (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Nabriva Therapeutics plc, an Irish incorporated public limited company (the “Company”), up to ______ Ordinary Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).